-
Racial Disparities in Biomarker Testing Rate, First-Line (1L) Treatment Patterns and Clinical Outcomes Among Real-World Patients in the United States (US) with Advanced or Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Mar 10, 2025, 14:00 PM -
Extrapolation of Impact on Individual Patient Outcomes in Neuromyelitis Optica Spectrum Disorder (NMOSD) Due to Relapse Reduction From Ravulizumab and Other Novel Biologic Treatments
Mar 10, 2025, 14:00 PM -
Cost and Use of Medical Devices in Incident Early-Onset Myasthenia Gravis Patients in France
Mar 10, 2025, 14:00 PM -
Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review
Mar 10, 2025, 14:00 PM -
Exploring the Value of Total/Near Total Skin Clearance in Patients With a History of Moderate-Severe Psoriasis: A Real-World Survey
Mar 10, 2025, 14:00 PM -
Timing of Health Technology Assessment in the United States: An Evaluation of ICER Reviews Over Seven Years
Mar 10, 2025, 14:00 PM -
Estimation of Treatment Eligible Patients With Transthyretin Cardiac Amyloidosis Within a Health Plan
Mar 10, 2025, 14:00 PM -
Pathways to Precision Cancer Care: Integrating Genetic Services into a Nationwide, Virtual Cancer Screening and Support Program
Mar 10, 2025, 14:00 PM -
Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada
Mar 10, 2025, 14:00 PM -
Severe Acute Respiratory Infection in a Pediatric Colombian Population: A Macro-Costing Approach
Mar 10, 2025, 14:00 PM -
Performance Assessment and Validation of Real-World Response Data Generated Using a Deep Learning-Based Natural Language Processing Model Across Multiple Solid Tumors
Mar 10, 2025, 14:00 PM -
Automating Health Economic Model Quality Check With a Model Generator
Mar 10, 2025, 14:00 PM -
Real-World Persistence to Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis in a Commercial and Medicare Advantage Population
Mar 10, 2025, 14:00 PM -
A Comparison of Single-Network and Multi-Site Approaches to Real-World Data Collection
Mar 10, 2025, 14:00 PM -
Sizing Up the Gap: Evaluating Sample Size Justification in Prospective Real-World Studies
Mar 10, 2025, 14:00 PM -
Characteristics of Adults With Type 2 Diabetes Who Are Not Treated With A Glucose-Lowering Agent: A Retrospective Cohort Study
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients With Fragile X Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
Assessing and Comparing Inpatient Hospitalization Outcomes for COPD in the United States and OECD Countries
Mar 10, 2025, 14:00 PM -
Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline
Mar 10, 2025, 14:00 PM -
Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study
Mar 10, 2025, 14:00 PM